Antimuscarinic treatment for overactive bladder symptoms: an all-time classic, yet still a clinical and basic challenge.


It has been a fascinating decade for antimuscarinics. Their clinical efficacy has been challenged and reinstated. New, efficacious extended-release formulations have broadened the therapeutic resources of physicians treating overactive bladder (OAB) sufferers. The mechanism of action has been revisited, and paradigm shifts have expanded clinical use… (More)
DOI: 10.1016/j.eururo.2010.12.022


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics